News

MycoFinder kit successfully completes EP 2.6.7 validation study

MycoFinder kit successfully completes EP 2.6.7 validation study

Nissui Pharma Solutions (NPS) has successfully completed an EP validation study in partnership with Confarma, a Solvias group company, specialized in biological analysis. MycoFinder, a mycoplasma gene detection kit, fulfils all requirements for EP 2.6.7. This...

Launch of NPS, Nissui Pharmaceutical (Japan) subsidiary in Europe.

Launch of NPS, Nissui Pharmaceutical (Japan) subsidiary in Europe.

Nissui Pharmaceutical Solutions (NPS) has been created by Nissui Pharmaceutical (Japan) as their European product development, sales and marketing subsidiary. Headquartered in Paris, NPS will develop and market products across Europe as part of the international...

NPS

NPS provides innovative solutions for QC/QA and product release of ATMPs and biopharmaceuticals. 

Contact us

Nissui Pharma Solutions
10, rue Mesnil
75116, Paris
France

Sales : contact@nissui-ps.com
Technical support : support@nissui-ps.com

*Required fields

For any information concerning the protection of personal data, please consult our privacy policy.

Copyright © Nissui Pharmasolutions, All rights reserved - Legal & credits - Terms of sales

Design by B-to-B Design